Evidence map›Paper›PMID 25551777›Full record

ArticleBMC veterinary research2014

Protective effects of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone chalcone in indomethacin-induced gastric erosive damage in rats.

Summaya M Dhiyaaldeen, Zahra A Amin, Pouya H Darvish, Iman Fahmi Mustafa, Mazen M Jamil, Elham Rouhollahi, Mahmood A Abdulla

Open access · goldAbstract read
In one paragraph

Article in BMC veterinary research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 42 citations in OpenAlex.

  1. The therapeutic potential ofTurkish journal of biology = Turk biyoloji dergisi · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Hydroxy Chalcones and Analogs with Chemopreventive Properties.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. The antiulcer effect ofDrug design, development and therapy · 2017
    Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Summaya M DhiyaaldeenDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. summaya_57@yahoo.com.
Zahra A AminDepartment of Pharmacognosy, College of Pharmacy, Hawler Medical University, 44001, Erbil, Iraq. zahraaalnajaar@yahoo.com.
Pouya H DarvishDepartment of Microbiology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. pouya_007@yahoo.com.
Iman Fahmi MustafaDepartment of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. imanfm@yahoo.com.
Mazen M JamilCenter of studies for Periodontology, Faculty of Denistry, University Teknologi Mara, 40450, Shah Alam, Malaysia. mazinmhd@gmail.com.
Elham RouhollahiDepartment of Pharmacology, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. elhamrou@yahoo.com.
Mahmood A AbdullaDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, 50603, Kuala Lumpur, Malaysia. ammeen@um.edu.my.
University of Malaya · MYHawler Medical University · IQUniversiti Teknologi MARA · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-steroidal anti-inflammatory drugs (NSAIDs) can result in peptic ulcer disease (PUD) which is a common condition worldwide. The aim of this study was to evaluate the antiulcer properties of (1-(4-hydroxy-phenyl)-3-m-tolyl-propenone) (HPTP) chalcone in rats using indomethacin as ulcerogenic agent.

resultsNone of the rats showed symptoms of kidney and liver toxicity during the term of the study. Administration of HPTP had decreased the acidity, increased gastric wall mucus and flattening of gastric mucosa and reducing erosive gastric damage area. HPTP also showed dose dependent increase in SOD, GPx activity and PGE2 level and decrease MDA. H & E stain showed decreased infiltration of leucocytes with edema of submucosal layer. PAS staining showed intense uptake of magenta color of gastric wall mucus in rats fed with HPTP, and immunohistochemical staining of gastric mucosa revealed over-expression of HSP70 protein, down-expression of Bax protein and over expression of TGF-β in rats administered with HPTP.

conclusionThis study has revealed that chalcone1-(4-hydroxy-phenyl)-3-m-tolyl-propenone can serve as a safe and effective antiulcer agent as it has been proved to increase pH and gastric wall mucus, increase GPx, SOD, PGE2, and decrease MDA level, ultimately, it has also contributes towards the over-expression of HSP protein andTGF-β, and down-expression of Bax protein.

Indexed as

AnimalsAnti-Inflammatory Agents, Non-SteroidalAnti-Ulcer AgentsChalconesFemaleGastric MucosaIndomethacinKidneyLipidsLiverMalePeptic UlcerRatsRats, Sprague-Dawley1-(4-hydroxyphenyl)-3-m-tolylpropenoneAnti-Inflammatory Agents, Non-SteroidalAnti-Ulcer AgentsChalconesIndomethacinLipids

Identifiers

PMID25551777
PMCPMC4339009
OpenAlexW2136536552

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.